Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.

Clinical trial NCT00544271 · TERMINATED

Trial details

NCT number: NCT00544271
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Diphtheria

Start date: 2003-05-01
Enrollment: 720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.